| (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of ID2 mRNA | CTD | PMID:16084531 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of ID2 mRNA | CTD | PMID:20146380 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1551192 | 6480464 | Ethinyl Estradiol results in decreased expression of ID2 mRNA | CTD | PMID:17942748 PMID:17555576 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:2859 | 6480464 | Ethinyl Estradiol results in decreased expression of ID2 mRNA | CTD | PMID:12655037 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:2859 | 6480464 | Ethinyl Estradiol results in decreased expression of ID2 mRNA | CTD | PMID:12655037 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1551192 | 6480464 | Ethinyl Estradiol results in decreased expression of ID2 mRNA | CTD | PMID:17555576 PMID:17942748 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:2859 | 6480464 | Ethinyl Estradiol results in decreased expression of ID2 mRNA | CTD | PMID:17557909 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:2859 | 6480464 | Ethinyl Estradiol results in decreased expression of ID2 mRNA | CTD | PMID:15834898 more ... |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of ID2 mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | decreases expression | ISO | RGD:1551192 | 6480464 | Estradiol results in decreased expression of ID2 mRNA | CTD | PMID:23144751 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of ID2 mRNA | CTD | PMID:20404318 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of ID2 mRNA | CTD | PMID:16541417 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ID2 mRNA | CTD | PMID:20106945 PMID:11489354 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1551192 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ID2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ID2 mRNA | CTD | PMID:11489354 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ID2 mRNA | CTD | PMID:11489354 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:2859 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ID2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1551192 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ID2 mRNA | CTD | PMID:17949056 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1551192 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ID2 mRNA | CTD | PMID:19933214 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2859 | 6480464 | 2,4-dinitrotoluene affects the expression of ID2 mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:1551192 | 6480464 | Glucosamine results in increased expression of ID2 mRNA | CTD | PMID:17178593 |
| 2-butoxyethanol | increases expression | ISO | RGD:1551192 | 6480464 | n-butoxyethanol results in increased expression of ID2 mRNA | CTD | PMID:19812364 |
| 2-methoxyethanol | decreases expression | ISO | RGD:2859 | 6480464 | methyl cellosolve results in decreased expression of ID2 mRNA | CTD | PMID:19643169 |
| 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of ID2 mRNA | CTD | PMID:21179406 |
| 3-aminobenzamide | decreases expression | EXP | | 6480464 | 3-aminobenzamide results in decreased expression of ID2 mRNA | CTD | PMID:15670817 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1551192 | 6480464 | Methylcholanthrene results in increased expression of ID2 mRNA | CTD | PMID:20713471 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [decitabine co-treated with vorinostat] affects the expression of ID2 mRNA | CTD | PMID:17330099 |
| 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | decitabine results in increased expression of ID2 mRNA | CTD | PMID:19194470 |
| 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of ID2 protein | CTD | PMID:15352031 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | TP53 protein promotes the reaction [Fluorouracil results in increased expression of ID2 mRNA] | CTD | PMID:16557594 |
| 5-fluorouracil | affects response to substance | ISO | RGD:1551192 | 6480464 | ID2 protein affects the susceptibility to Fluorouracil | CTD | PMID:15016739 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of ID2 mRNA | CTD | PMID:16557594 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | ID2 protein affects the susceptibility to Fluorouracil | CTD | PMID:15352031 |
| acetylsalicylic acid | affects expression | ISO | RGD:2859 | 6480464 | Aspirin affects the expression of ID2 mRNA | CTD | PMID:12800193 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:1551192 | 6480464 | Glucosamine results in increased expression of ID2 mRNA | CTD | PMID:17178593 |
| all-trans-retinoic acid | affects expression | EXP | | 6480464 | Tretinoin affects the expression of ID2 mRNA | CTD | PMID:16054129 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of ID2 mRNA | CTD | PMID:15894607 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ID2 mRNA | CTD | PMID:15894607 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ID2 mRNA | CTD | PMID:16129123 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ID2 mRNA | CTD | PMID:17138961 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ID2 mRNA | CTD | PMID:16129123 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ID2 mRNA | CTD | PMID:16129123 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ID2 mRNA | CTD | PMID:17138961 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ID2 mRNA | CTD | PMID:17218384 more ... |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of ID2 mRNA | CTD | PMID:17310985 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ID2 mRNA | CTD | PMID:17218384 more ... |
| ammonium chloride | affects expression | ISO | RGD:2859 | 6480464 | Ammonium Chloride affects the expression of ID2 mRNA | CTD | PMID:16483693 |
| Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of ID2 mRNA | CTD | PMID:16934159 |
| arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of ID2 mRNA | CTD | PMID:16835338 |
| benzene | multiple interactions | ISO | RGD:2859 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ID2 mRNA | CTD | PMID:17905399 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1551192 | 6480464 | Benzo(a)pyrene results in decreased expression of ID2 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | increases expression | ISO | RGD:1551192 | 6480464 | Benzo(a)pyrene results in increased expression of ID2 mRNA | CTD | PMID:22228805 |
| beta-D-glucosamine | increases expression | ISO | RGD:1551192 | 6480464 | Glucosamine results in increased expression of ID2 mRNA | CTD | PMID:17178593 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:1551192 | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of ID2 mRNA] | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1551192 | 6480464 | Diethylhexyl Phthalate results in decreased expression of ID2 mRNA | CTD | PMID:19850644 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ID2 mRNA | CTD | PMID:22576693 |
| butyric acid | increases expression | ISO | RGD:2859 | 6480464 | Butyric Acid results in increased expression of ID2 mRNA | CTD | PMID:12800193 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ID2 mRNA | CTD | PMID:12634122 |
| cadmium dichloride | decreases expression | ISO | RGD:2859 | 6480464 | Cadmium Chloride results in decreased expression of ID2 mRNA | CTD | PMID:18636176 |
| calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of ID2 mRNA | CTD | PMID:16002434 |
| chloroprene | decreases expression | ISO | RGD:1551192 | 6480464 | Chloroprene results in decreased expression of ID2 mRNA | CTD | PMID:23125180 |
| chloroprene | increases expression | ISO | RGD:2859 | 6480464 | Chloroprene results in increased expression of ID2 mRNA | CTD | PMID:23125180 |
| choline | multiple interactions | ISO | RGD:1551192 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ID2 mRNA | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:1551192 | 6480464 | Ciguatoxins affects the expression of ID2 mRNA | CTD | PMID:18353800 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of ID2 mRNA | CTD | PMID:21603599 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of ID2 mRNA | CTD | PMID:19561079 PMID:21603599 |
| clozapine | increases expression | ISO | RGD:2859 | 6480464 | Clozapine results in increased expression of ID2 mRNA | CTD | PMID:12437575 |
| copper atom | decreases expression | ISO | RGD:2859 | 6480464 | Copper results in decreased expression of ID2 mRNA | CTD | PMID:22465980 |
| copper atom | multiple interactions | ISO | RGD:1551192 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ID2 mRNA | CTD | PMID:15467011 |
| copper(0) | decreases expression | ISO | RGD:2859 | 6480464 | Copper results in decreased expression of ID2 mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | ISO | RGD:1551192 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ID2 mRNA | CTD | PMID:15467011 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of ID2 mRNA | CTD | PMID:19549813 |
| copper(II) chloride | affects expression | EXP | | 6480464 | cupric chloride affects the expression of ID2 mRNA | CTD | PMID:17211630 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of ID2 mRNA | CTD | PMID:21594647 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ID2 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1551192 | 6480464 | Cyclosporine results in decreased expression of ID2 mRNA | CTD | PMID:19770486 |
| Delta(9)-tetrahydrocannabinol | increases expression | EXP | | 6480464 | Tetrahydrocannabinol results in increased expression of ID2 mRNA | CTD | PMID:18454173 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of ID2 mRNA | CTD | PMID:22048647 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of ID2 mRNA | CTD | PMID:15761015 |
| diarsenic trioxide | increases expression | ISO | RGD:1551192 | 6480464 | arsenic trioxide results in increased expression of ID2 mRNA | CTD | PMID:21921037 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of ID2 mRNA | CTD | PMID:15894607 |
| dibenz[a,h]anthracene | increases expression | EXP | | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of ID2 mRNA | CTD | PMID:16269432 |
| dibenzo[a,l]pyrene | increases expression | EXP | | 6480464 | dibenzo(a,l)pyrene results in increased expression of ID2 mRNA | CTD | PMID:16269432 |
| dibutyl phthalate | increases expression | ISO | RGD:1551192 | 6480464 | Dibutyl Phthalate results in increased expression of ID2 mRNA | CTD | PMID:21266533 |
| dichlorine | multiple interactions | ISO | RGD:2859 | 6480464 | [Ozone co-treated with Chlorine] affects the expression of ID2 mRNA | CTD | PMID:18636392 |
| dichlorine | decreases expression | ISO | RGD:2859 | 6480464 | Chlorine results in decreased expression of ID2 mRNA | CTD | PMID:18636392 |
| dichromium trioxide | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ID2 mRNA | CTD | PMID:12634122 |
| diethylstilbestrol | decreases expression | ISO | RGD:1551192 | 6480464 | Diethylstilbestrol results in decreased expression of ID2 mRNA | CTD | PMID:21922642 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of ID2 mRNA | CTD | PMID:17175027 |
| doxorubicin | affects response to substance | EXP | | 6480464 | ID2 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 |
| doxorubicin | affects expression | ISO | RGD:2859 | 6480464 | Doxorubicin affects the expression of ID2 mRNA | CTD | PMID:12187937 |
| elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of ID2 mRNA | CTD | PMID:19244175 |
| fenofibrate | decreases expression | ISO | RGD:1551192 | 6480464 | Fenofibrate results in decreased expression of ID2 mRNA | CTD | PMID:11798191 |
| folic acid | multiple interactions | ISO | RGD:1551192 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ID2 mRNA | CTD | PMID:20938992 |
| formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of ID2 mRNA | CTD | PMID:20655997 |
| haloperidol | decreases expression | ISO | RGD:2859 | 6480464 | Haloperidol results in decreased expression of ID2 mRNA | CTD | PMID:12437575 |
| haloperidol | increases expression | ISO | RGD:2859 | 6480464 | Haloperidol results in increased expression of ID2 mRNA | CTD | PMID:12437575 |
| harmine | multiple interactions | ISO | RGD:1551192 | 6480464 | Harmine inhibits the reaction [WNT3A protein results in decreased expression of ID2 mRNA] | CTD | PMID:20519739 |
| hydrogen chloride | increases expression | EXP | | 6480464 | Hydrochloric Acid results in increased expression of ID2 mRNA | CTD | PMID:15046208 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of ID2 mRNA | CTD | PMID:20044591 |
| L-methionine | multiple interactions | ISO | RGD:1551192 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ID2 mRNA | CTD | PMID:20938992 |
| lead diacetate | multiple interactions | EXP | | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ID2 mRNA | CTD | PMID:12634122 |
| linalool | increases expression | EXP | | 6480464 | linalool results in increased expression of ID2 mRNA | CTD | PMID:19922762 |
| manganese atom | increases expression | EXP | | 6480464 | Manganese results in increased expression of ID2 mRNA | CTD | PMID:17175027 |
| manganese(0) | increases expression | EXP | | 6480464 | Manganese results in increased expression of ID2 mRNA | CTD | PMID:17175027 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of ID2 mRNA | CTD | PMID:17175027 |
| methylmercury(1+) | multiple interactions | ISO | RGD:2859 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ID2 mRNA | CTD | PMID:17905399 |
| N-acetyl-L-cysteine | decreases expression | EXP | | 6480464 | Acetylcysteine results in decreased expression of ID2 mRNA | CTD | PMID:16084531 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of ID2 mRNA | CTD | PMID:16780908 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of ID2 mRNA | CTD | PMID:16780908 PMID:20146380 |
| nitroglycerin | increases expression | ISO | RGD:2859 | 6480464 | Nitroglycerin results in increased expression of ID2 mRNA | CTD | PMID:12102619 |
| ozone | multiple interactions | ISO | RGD:2859 | 6480464 | [Ozone co-treated with Chlorine] affects the expression of ID2 mRNA | CTD | PMID:18636392 |
| paracetamol | decreases expression | ISO | RGD:1551192 | 6480464 | Acetaminophen results in decreased expression of ID2 mRNA | CTD | PMID:17585979 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ID2 mRNA | CTD | PMID:22230336 |
| paracetamol | affects expression | ISO | RGD:1551192 | 6480464 | Acetaminophen affects the expression of ID2 mRNA | CTD | PMID:17562736 |
| perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:1551192 | 6480464 | perfluorooctane sulfonic acid affects the expression of ID2 mRNA | CTD | PMID:19429403 |
| perfluorooctanoic acid | affects expression | ISO | RGD:1551192 | 6480464 | perfluorooctanoic acid affects the expression of ID2 mRNA | CTD | PMID:19429403 |
| phenobarbital | multiple interactions | ISO | RGD:1551192 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ID2 mRNA] | CTD | PMID:19482888 |
| phenobarbital | decreases expression | ISO | RGD:2859 | 6480464 | Phenobarbital results in decreased expression of ID2 mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases expression | ISO | RGD:1551192 | 6480464 | Phenobarbital results in decreased expression of ID2 mRNA | CTD | PMID:19482888 |
| pioglitazone | multiple interactions | EXP | | 6480464 | [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; more ... | CTD | PMID:20847119 |
| pirinixic acid | multiple interactions | ISO | RGD:1551192 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of ID2 mRNA] | CTD | PMID:20059764 |
| pirinixic acid | decreases expression | ISO | RGD:1551192 | 6480464 | pirinixic acid results in decreased expression of ID2 mRNA | CTD | PMID:11798191 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1551192 | 6480464 | pirinixic acid results in decreased expression of ID2 mRNA | CTD | PMID:18445702 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1551192 | 6480464 | pirinixic acid results in decreased expression of ID2 mRNA | CTD | PMID:11798191 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1551192 | 6480464 | pirinixic acid results in decreased expression of ID2 mRNA | CTD | PMID:20059764 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1551192 | 6480464 | pirinixic acid results in decreased expression of ID2 mRNA | CTD | PMID:18445702 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1551192 | 6480464 | pirinixic acid results in decreased expression of ID2 mRNA | CTD | PMID:11798191 more ... |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:2859 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of ID2 mRNA | CTD | PMID:19162173 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of ID2 mRNA | CTD | PMID:18037150 |
| propiconazole | decreases expression | ISO | RGD:1551192 | 6480464 | propiconazole results in decreased expression of ID2 mRNA | CTD | PMID:21278054 |
| prostaglandin F2alpha | decreases expression | ISO | RGD:2859 | 6480464 | Dinoprost results in decreased expression of ID2 mRNA | CTD | PMID:11517196 |
| quercetin | affects expression | EXP | | 6480464 | Quercetin affects the expression of ID2 mRNA | CTD | PMID:21632981 |
| ranitidine | multiple interactions | ISO | RGD:2859 | 6480464 | Ranitidine inhibits the reaction [Lipopolysaccharides results in decreased expression of ID2 mRNA] | CTD | PMID:16415329 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; more ... | CTD | PMID:20847119 |
| selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of ID2 mRNA | CTD | PMID:19244175 |
| sevoflurane | affects expression | ISO | RGD:2859 | 6480464 | sevoflurane affects the expression of ID2 mRNA | CTD | PMID:15967596 |
| silicon dioxide | increases expression | ISO | RGD:1551192 | 6480464 | Silicon Dioxide results in increased expression of ID2 mRNA | CTD | PMID:19073995 |
| tamoxifen | affects expression | ISO | RGD:1551192 | 6480464 | Tamoxifen affects the expression of ID2 mRNA | CTD | PMID:20937368 PMID:17555576 |
| tamoxifen | affects expression | ISO | RGD:1551192 | 6480464 | Tamoxifen affects the expression of ID2 mRNA | CTD | PMID:17555576 PMID:20937368 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1551192 | 6480464 | tert-Butylhydroperoxide results in increased expression of ID2 mRNA | CTD | PMID:15003993 PMID:14729362 |
| tert-butyl hydroperoxide | multiple interactions | EXP | | 6480464 | [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; more ... | CTD | PMID:20847119 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of ID2 mRNA | CTD | PMID:20847119 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1551192 | 6480464 | tert-Butylhydroperoxide results in increased expression of ID2 mRNA | CTD | PMID:14729362 PMID:15003993 |
| thioacetamide | decreases expression | ISO | RGD:2859 | 6480464 | Thioacetamide results in decreased expression of ID2 mRNA | CTD | PMID:16297948 |
| trichloroethene | multiple interactions | ISO | RGD:2859 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ID2 mRNA | CTD | PMID:17905399 |
| troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; more ... | CTD | PMID:20847119 |
| uranium atom | affects expression | EXP | | 6480464 | Uranium affects the expression of ID2 mRNA | CTD | PMID:15672453 |
| valproic acid | affects expression | ISO | RGD:1551192 | 6480464 | Valproic Acid affects the expression of ID2 mRNA | CTD | PMID:17292431 |
| valproic acid | increases expression | ISO | RGD:1551192 | 6480464 | Valproic Acid results in increased expression of ID2 mRNA | CTD | PMID:21427059 |
| valsartan | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [AGT protein results in decreased expression of ID2 mRNA] | CTD | PMID:19225232 |
| vincaleukoblastine | affects response to substance | EXP | | 6480464 | ID2 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 |
| zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ID2 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ID2 mRNA | CTD | PMID:18593933 |